| Not Yet Recruiting | Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide NCT06740812 | Montefiore Medical Center | Phase 4 |
| Not Yet Recruiting | A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use NCT07446439 | Vanda Pharmaceuticals | Phase 3 |
| Recruiting | Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis NCT07403370 | Shandong Cancer Hospital and Institute | — |
| Enrolling By Invitation | Exploring the Effect of Aromatherapy NCT07155876 | Baptist Health South Florida | N/A |
| Recruiting | Prevalence of Hyperemesis Gravidarum NCT06415084 | University Hospital, Clermont-Ferrand | — |
| Recruiting | Antiemetic Fosaprepitant To Remedy Nausea and Vomiting NCT06382012 | Montefiore Medical Center | Phase 2 / Phase 3 |
| Recruiting | Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breas NCT06314906 | Feixue Song | Phase 3 |
| Unknown | the Efficacy and Safety of Ondansetron Oral Soluble Pellicles NCT06282211 | The First Affiliated Hospital of Xinxiang Medical College | Phase 3 |
| Recruiting | Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Canc NCT06200168 | Jiuda Zhao | Phase 3 |
| Completed | Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation NCT06045364 | Jie Chen | Phase 1 / Phase 2 |
| Unknown | A Clinical Study to Evaluate Cyclopofol Injection for the Prevention of Postoperative Nausea and Vomiting NCT05837156 | Mengchang Yang | Phase 1 |
| Completed | Efficacy of Three Antiemetics in Preventing Nausea and Vomiting NCT05533281 | The Second Affiliated Hospital of Chongqing Medical University | Phase 4 |
| Recruiting | The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV NCT05690802 | Xijing Hospital | N/A |
| Completed | The Impact of Oral Cryotherapy and Chewing Gum Interventions NCT07145320 | Hacettepe University | N/A |
| Completed | Effect of Inhaled Aromatherapy on Chemo-Induced Nausea Vomiting (NCVI): CINVAROM (Chemotherapy Induced Nausea NCT04560114 | Centre Francois Baclesse | Phase 2 |
| Unknown | Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery NCT05016180 | Tianjin Medical University General Hospital | Phase 2 |
| Completed | The Preventive Effects of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate NCT03185156 | West China Second University Hospital | Phase 4 |
| Completed | Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patien NCT02116530 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Comparison of the Effect of Ondansetron and Combined Ondansetron and Betahistine on Postoperative Nausea and V NCT02026778 | Yonsei University | N/A |
| Recruiting | Domperidone in Treating Patients With Gastrointestinal Disorders NCT01696734 | M.D. Anderson Cancer Center | Phase 3 |
| Unknown | Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension NCT01669213 | Seoul National University Hospital | N/A |
| Completed | Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemothe NCT01553578 | Wake Forest University Health Sciences | N/A |
| Terminated | Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherap NCT01275664 | Gynecologic Oncology Group | N/A |
| Completed | Supportive Intervention Programs Study NCT01590147 | Wake Forest University | N/A |
| Unknown | Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, NCT01372787 | Gynecologic Oncology Group | — |
| Terminated | Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain NCT00930332 | NCIC Clinical Trials Group | Phase 1 |
| Withdrawn | A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic NCT00891761 | GlaxoSmithKline | Phase 3 |
| Terminated | Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Prim NCT00903396 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy NCT00880191 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Cau NCT00895245 | University of Washington | Phase 2 |
| Completed | Reduction of Postoperative Pain, Nausea and Vomiting NCT01718132 | Triemli Hospital | — |
| Completed | Acupressure Wristbands or Standard Care in Controlling Nausea Caused by Chemotherapy NCT00978185 | University of Manchester | Phase 3 |
| Terminated | Blood Samples From Patients on a Clinical Trial to CINV During HSCT NCT00900068 | OHSU Knight Cancer Institute | — |
| Completed | Hypnosis in Reducing Pain and Other Side Effects in Women Undergoing Surgery for Breast Cancer NCT00748267 | City of Hope Medical Center | N/A |
| Completed | Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer NCT00902733 | City of Hope Medical Center | N/A |
| Withdrawn | Nurse-Provided Care or Standard Care in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer NCT00903305 | City of Hope Medical Center | N/A |
| Completed | Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Canc NCT00978549 | Cambridge University Hospitals NHS Foundation Trust | Phase 3 |
| Withdrawn | Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer NCT00499668 | Vanderbilt-Ingram Cancer Center | N/A |
| Terminated | A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiti NCT00418678 | Veeda Oncology | Phase 4 |
| Completed | APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in NCT00343460 | Heron Therapeutics | Phase 3 |
| Completed | Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX NCT00381862 | OHSU Knight Cancer Institute | Phase 2 |
| Terminated | Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients NCT02550119 | University of Southern California | N/A |
| Completed | Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in NCT00343863 | University of Washington | N/A |
| Completed | Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer NCT00719173 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Completed | Acupressure in Preventing Nausea and Vomiting in Young Cancer Patients Receiving Chemotherapy NCT00310063 | Wake Forest University Health Sciences | N/A |
| Completed | Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department NCT00590317 | Emory University | Phase 2 |
| Completed | Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy NCT00169572 | GlaxoSmithKline | Phase 2 |
| Completed | Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Be NCT00293384 | Barbara Ann Karmanos Cancer Institute | N/A |
| Completed | UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer NCT00064272 | University of Michigan Rogel Cancer Center | Phase 2 |
| Completed | Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer NCT00020657 | Gary Morrow | Phase 3 |
| Completed | Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer NCT00179348 | Albert Einstein College of Medicine | N/A |
| Completed | Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Tre NCT00006348 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy NCT00005994 | University of Rochester | N/A |
| Completed | Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer NCT00416689 | Alliance for Clinical Trials in Oncology | — |
| Completed | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery NCT00004895 | Northwestern University | Phase 2 |
| Completed | Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy NCT00003817 | Gary Morrow | Phase 2 |
| Completed | Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer NCT00003685 | NCIC Clinical Trials Group | Phase 3 |
| Completed | Drugs to Reduce the Side Effects of Chemotherapy NCT00003213 | Swiss Cancer Institute | Phase 3 |
| Unknown | Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation The NCT00004219 | Simbec Research | Phase 3 |